2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
2006
HIV Vaccines and Microbicides Resource Tracking Working Group. Adding it all up: Funding for HIV vaccine and microbicide development, 2000 to 2005. August 2006. Official website of the HIV Vaccines and Microbicides Resource Tracking Working Group.
2005
Abner SR, Guenthner PC, Guarner J, et al. A Human Colorectal Explant Culture to Evaluate Topical Microbicides for the Prevention of HIV Infection. J Infect Dis. 2005 Nov 1;192(9):1545-56.
Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol. 2005 Oct;5(10):783-92.
Harrison PF, Lamphear TL. Microbicides. In: Mayer KH, Pizer HF, eds. The AIDS Pandemic: Impact on Science and Society. Elsevier Academic Press; 2005: 190-235.
IWGM Workshop on North-South International Collaboration in Microbicide Research: Report of meeting held on 24 April, 2006 in Cape Town, South Africa. Saxena B, Rapporteur. 2006.
Tracking Funding for Microbicide Research & Development: Estimates of Annual Investments 2000 to 2005.
UNAIDS. Financing the expanded response to AIDS: HIV vaccine and microbicide research and development, 2005.
2004
Lard-Whiteford SL, Matecka D, O'Rear JJ, et al. Recommendations for the Nonclinical Development of Topical Microbicides for Prevention of HIV Transmission: An Update. JAIDS. 36(1): 2004, 541-52.
International Family Health, London School of Hygiene and Tropical Medicine, and Global Campaign for Microbicides. A Comparison of the Potential Impact of Microbicides in Two Contrasting African Settings, Johannesburg, South Africa and Cotonou, Benin, August 2004.
Kumaranayake L, Terris-Prestholt F, Watts C. Preparing to Deliver: Introduction of Microbicides, July 2004.
Watts C, Foss A, Vickerman P, et al. Microbicide Awareness, Investment and Demand: Advocacy and Networking to Accelerate Microbicide Development and Availability, July 2004.
International Family Health, ICHAP, London School of Hygiene and Tropical Medicine, Global Campaign for Microbicides. The Potential Impact of Microbicides in Bagalkot, District, Karnataka, India: Model Projections and Implications for Product Promotion, June 2004.
International Family Health and London School of Hygiene and Tropical Medicine. The Potential Impact of Microbicides in Johannesburg, South Africa: Model Projections and Implications for Product Promotion, April 2004.
Microbicides 2004. 28-31 March 2004. London, United Kingdom. Microbicides 2004 Abstract Book.
UK Campaign for Microbicides. Microbicides: Preventing HIV and STI Transmission: A Source Document for Advocates, January 2004.
2003
Foss AM, Vickerman PT, Heise L, Watts CH. Shifts in condom use following microbicide introduction: should we be concerned? AIDS 17(8):1227-37, 2003.
Harrison PF, Rosenberg Z, Bowcut J. Topical Microbicides for Disease Prevention: Status and Challenges. Clinical Infectious Diseases. 36: 2003, 1290-4.
Moore JP, Shattock RJ. Preventing HIV-1 sexual transmission- not sexy enough science, or no benefit to the bottom-line? Journal of Antimicrobial Chemotherapy. 52(6): 2003, 890-2.
International Family Health and London School of Hygiene and Tropical Medicine. Are People Using Condoms? November 2003.
2002
Bollen LJM, Kilmarx PH, Wiwawongwana P. Photo Atlas for Microbicide Evaluation. Bangkok: Thailand MOPH-US CDC Collaboration; 2002 .
Johnston R. Microbicides 2002: An Update. AIDS Patient Care and STDs. 16(9): 2002, 419-30.
Stone A. Microbicides: A New Approach to Preventing HIV and Other Sexually Transmitted Infections. Nature Reviews: Drug Discovery. 1: 2002, 977-85.
Microbicides 2002. 12-15 May 2002. Antwerp, Belgium.
2001
Garg S, Tambwekar KR, Vermani K, et al. Compendium of Pharmaceutical Excipients for Vaginal Formulations. Pharmaceutical Technology Drug Delivery. 2001, 14-24.
Mauck C, Rosenberg Z, Van Damme L. Recommendations for the Clinical Development of Topical Microbicides: An Update. AIDS. 15: 2001, 857-68.
Population Council and International Family Health. The Case for Microbicides: A Global Priority, 2001.
WHO/CONRAD Technical Consultation on Nonoxynol-9. Summary Report. World Health Organization, Geneva, 9-10 October 2001.
American Foundation for AIDS Research (amfAR). Creating a Research and Development Agenda for Rectal Microbicides that Protect Against HIV Infection. Report from the Workshop: Baltimore, Maryland, June 7-8, 2001.
2000
Vermani K, Garg S. The Scope and Potential of Vaginal Drug Delivery. PSTT. 3(10): 2000, 359-64.
Rockefeller Foundation Initiative Reports. June 2000.